[Translation] A randomized, double-blind, placebo-controlled, parallel-group adaptive phase IIb/III trial evaluating the efficacy and safety of TNM001 injection in the prevention of lower respiratory tract infection caused by respiratory syncytial virus in infants under 1 year old
评估TNM001和安慰剂相比在婴儿人群中预防RSV LRTI的有效性、安全性、PK特征、中和抗体和免疫原性
[Translation] To evaluate the efficacy, safety, PK profile, neutralizing antibodies, and immunogenicity of TNM001 versus placebo for the prevention of RSV LRTI in the infant population